Envoy Medical to Present at the Planet MicroCap Showcase

Vegas 2024

WHITE BEAR LAKE, Minnesota, April 24, 2024 (GLOBE NEWSWIRE) --  Envoy Medical, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that David R. Wells, Chief Financial Officer, will present a corporate overview at the Planet MicroCap Showcase: VEGAS 2024. The conference is being held on April 30 – May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV.

Presentation Date:         May 1, 2024

Time:                              8:30am Pacific Time (Track 2)                        

Webcast Link:                https://www.webcaster4.com/Webcast/Page/3026/50121

Mr. Wells will be available for one-on-one meetings throughout the conference. Investors can attend the conference and request a meeting with Mr. Wells by registering at the link below:

https://planetmicrocapshowcase.com/signup

For investors who are unable to attend the conference, all company presentations will be available directly on the conference event platform on the “Agenda” tab at the link below:

https://planetmicrocapshowcase.com/agenda

About the Fully Implanted Acclaim Cochlear Implant

We believe the fully implanted Acclaim Cochlear Implant (“Acclaim CI”) will be a first-of-its-kind fully implanted cochlear implant. Envoy Medical’s fully implanted technology includes a sensor designed to leverage the natural anatomy of the ear instead of a microphone to capture sound.

The Acclaim CI is designed to address severe to profound sensorineural hearing loss that is not adequately addressed by hearing aids. The Acclaim CI is expected to be indicated for adults who have been deemed adequate candidates by a qualified physician.

The Acclaim Cochlear Implant received the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) in 2019. We believe the Acclaim CI was the first hearing-focused device to receive Breakthrough Device Designation.

CAUTION The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by United States law to investigational use.

About the Esteem Fully Implanted Active Middle Ear Implant (FI-AMEI)